norfloxacin has been researched along with Group A Strep Infection in 17 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the study was to examine the characteristics of spontaneous bacterial peritonitis (SBP) caused by streptococci, in particular viridans group streptococci (VGS), and to investigate a potential association between the long-term administration of norfloxacin and high-level resistance to fluoroquinolones in these organisms." | 3.73 | Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. ( Bert, F; Lambert-Zechovsky, N; Noussair, L; Valla, D, 2005) |
| "FIC, AI-2 activity assay, real-time RT-PCR and biofilm inhibition assays were performed to investigate the in vitro effect of paeoniflorin combined with norfloxacin." | 1.72 | Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection. ( Fan, Q; Grenier, D; Hou, X; Li, J; Sun, L; Wang, Y; Wei, Y; Xue, B; Yi, L; Zhang, X; Zuo, J, 2022) |
| " FQs at proper dosage can be effective against S." | 1.39 | Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. ( Balaji, K; Pandian, SK; Thenmozhi, R, 2013) |
| "Hepatopulmonary syndrome was diagnosed after demonstration of the presence of a massive intrapulmonary shunt." | 1.31 | Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. ( Añel, RM; Sheagren, JN, 2001) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| "Pefloxacin was given as the single drug (except in one case) to twenty-seven patients with a variety of infections (bone and/or joint: 8; respiratory tract: 6; urinary tract: 5; bacteremia: 4; meninges: 3; other: 1)." | 1.27 | [Pefloxacin: clinical experience]. ( Bertrand, A; Janbon, F; Jonquet, O; Jourdan, J; Santoni, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Montes, M | 1 |
| Tamayo, E | 1 |
| Orden, B | 1 |
| Larruskain, J | 1 |
| Perez-Trallero, E | 1 |
| Li, J | 1 |
| Fan, Q | 1 |
| Zuo, J | 1 |
| Xue, B | 1 |
| Zhang, X | 1 |
| Wei, Y | 1 |
| Sun, L | 1 |
| Grenier, D | 1 |
| Yi, L | 1 |
| Hou, X | 1 |
| Wang, Y | 1 |
| Balaji, K | 1 |
| Thenmozhi, R | 1 |
| Pandian, SK | 1 |
| Pires, R | 1 |
| Ardanuy, C | 1 |
| Rolo, D | 1 |
| Morais, A | 1 |
| Brito-Avô, A | 1 |
| Gonçalo-Marques, J | 1 |
| Liñares, J | 1 |
| Santos-Sanches, I | 1 |
| Bert, F | 1 |
| Noussair, L | 1 |
| Lambert-Zechovsky, N | 1 |
| Valla, D | 1 |
| Broun, ER | 1 |
| Wheat, JL | 1 |
| Kneebone, PH | 1 |
| Sundblad, K | 1 |
| Hromas, RA | 1 |
| Tricot, G | 1 |
| Bow, EJ | 1 |
| Mandell, LA | 1 |
| Louie, TJ | 1 |
| Feld, R | 1 |
| Palmer, M | 1 |
| Zee, B | 1 |
| Pater, J | 1 |
| Barrio, J | 1 |
| Castiella, A | 1 |
| López, P | 1 |
| Indart, A | 1 |
| Arenas, JI | 1 |
| Añel, RM | 1 |
| Sheagren, JN | 1 |
| Rodríguez-Avial, I | 1 |
| Rodríguez-Avial, C | 1 |
| Picazo, JJ | 1 |
| Huber-Spitzy, V | 1 |
| Baumgartner, I | 1 |
| Arocker-Mettinger, E | 1 |
| Schiffbänker, M | 1 |
| Georgiew, L | 1 |
| Grabner, G | 1 |
| Classen, DC | 1 |
| Burke, JP | 1 |
| Ford, CD | 1 |
| Evershed, S | 1 |
| Aloia, MR | 1 |
| Wilfahrt, JK | 1 |
| Elliott, JA | 1 |
| Schmeiser, T | 1 |
| Kurrle, E | 1 |
| Arnold, R | 1 |
| Wiesneth, M | 1 |
| Bunjes, D | 1 |
| Hertenstein, B | 1 |
| Kern, W | 1 |
| Heit, W | 1 |
| Heimpel, H | 1 |
| Gargallo, D | 1 |
| Moros, M | 1 |
| Coll, R | 1 |
| Esteve, M | 1 |
| Parés, J | 1 |
| Xicota, MA | 1 |
| Guinea, J | 1 |
| Esko, E | 1 |
| Renkonen, OV | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
| Bertrand, A | 1 |
| Janbon, F | 1 |
| Jourdan, J | 1 |
| Jonquet, O | 1 |
| Santoni, A | 1 |
2 trials available for norfloxacin and Group A Strep Infection
| Article | Year |
|---|---|
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Topics: Acyclovir; Adult; Bacteremia; Bone Marrow Transplantation; Female; Fever; Fluconazole; Gram-Positive | 1994 |
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacteremia; Colony Count, Microbial; Fema | 1996 |
15 other studies available for norfloxacin and Group A Strep Infection
| Article | Year |
|---|---|
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Ba | 2010 |
Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Drug Resistance, Bacterial; Fluoroquin | 2022 |
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Se | 2013 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Protei | 2010 |
Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Drug Administration Schedule; Drug Resistance, Bacterial; Fema | 2005 |
[Spontaneous bacterial peritonitis caused by Streptococcus milleri in a cirrhotic patient with selective intestinal decontamination].
Topics: Aged; Anti-Infective Agents; Humans; Intestines; Liver Cirrhosis, Alcoholic; Male; Norfloxacin; Peri | 1998 |
Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents.
Topics: Adult; Anti-Infective Agents; Brain Abscess; Hepatopulmonary Syndrome; Humans; Male; Nitric Oxide; N | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, M | 2001 |
[Corneal ulcer. Current analysis from specialized ambulatory care of a clinic].
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Contact Lenses, Extended-Wear; Corneal | 1992 |
Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Drug Re | 1990 |
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Bone Marrow Transplantation; Female; Human | 1988 |
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Chemical Phenomena; Chemis | 1988 |
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefaclor; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; | 1985 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |
[Pefloxacin: clinical experience].
Topics: Acinetobacter Infections; Adult; Aged; Bacterial Infections; Enterobacteriaceae Infections; Enteroco | 1985 |